Depression trials recruiting in Texas

All Depression trials nationally

Cities in Texas

Recruiting trials in Texas

• A Computerized Depression Intervention in Veterans
  NCT06217198 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Waco
• A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
  NCT07115329 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · Texas: Atascocita, DeSoto
• A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
  NCT07592689 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Texas: Austin
• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
  NCT03887715 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Dallas, El Paso, Houston
• A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
  NCT07172516 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Texas: Atascocita, Houston, Wichita Falls
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
  NCT06775379 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Texas: Plano, Wichita Falls
• A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
  NCT07076407 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Texas: Austin
• A Study of Brenipatide in Adult Participants With Major Depressive Disorder
  NCT07412756 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: DeSoto, Fort Worth, Shavano Park
• A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
  NCT06793397 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Texas: Austin, Fort Worth, Houston, San Antonio
• A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
  NCT06696755 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Austin, Houston, Missouri City, Richardson
• A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
  NCT04777357 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · Texas: Austin, Beaumont, Bellaire, Coppell
• A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
  NCT07276997 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Austin, Bellaire, Richardson
• A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
  NCT06524830 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Austin, DeSoto, Plano
• A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
  NCT07621237 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, McKinney, Plano
• A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
  NCT07610473 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: DeSoto, Fort Worth
• A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
  NCT07300969 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Austin, DeSoto, Richardson, Wichita Falls
• A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
  NCT07105111 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin
• A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
  NCT07227454 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Texas: Houston
• A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
  NCT07065240 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Dallas, Irving, Richardson
• A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
  NCT06223880 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Dallas, Friendswood, San Antonio, Wichita Falls
• A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT07196501 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Austin, Bellaire, Friendswood, Stafford
• ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
  NCT07284667 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Houston, Katy, The Woodlands
• ACT for Individuals With MNCD and Their Care Partners
  NCT07239609 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Lubbock
• ALTO-100 in Bipolar Disorder With Depression (BD-D)
  NCT06656416 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: Houston
• ALTO-207 in Adults With Treatment-resistant Depression (TRD)
  NCT07553637 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Texas: Dallas, Fort Worth, Galveston, Houston
• Accelerated Intermittent Theta Burst in Treatment-Naive Adolescents
  NCT06523439 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 20 Years · Sex: All (male and female) · Texas: Austin
• Accelerated rTMS for Substance Use Disorder and Depression
  NCT06424184 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Dallas
• Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
  NCT06706232 · Phase: Phase 2 · Ages: 25 Years to 70 Years · Sex: All (male and female) · Texas: Houston
• Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Bipolar Depression
  NCT03522545 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Houston
• BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women
  NCT07413692 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 60 Years · Sex: Female · Texas: Dallas
• Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors
  NCT06864715 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · Texas: Houston
• Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia
  NCT07060066 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 60 Years · Sex: All (male and female) · Texas: Houston
• Cancer Pain Management Using a Web-based Intervention
  NCT06085313 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Texas: Austin
• Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
  NCT07484217 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Austin, Bellaire, Dallas, Houston
• Clinical Trial on Agitation in Alzheimer's Dementia
  NCT05543681 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · Texas: Austin, Dallas
• Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
  NCT06526078 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Houston
• Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
  NCT05474846 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Confirmatory Efficacy Trial of Attention Bias Modification for Depression
  NCT06361095 · Phase: Early Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: Austin
• DBS for Depression
  NCT03437928 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 70 Years · Sex: All (male and female) · Texas: Dallas, Houston
• Deep Brain Stimulation of Treatment-Resistant Bipolar Depression
  NCT06599099 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 64 Years · Sex: All (male and female) · Texas: Houston
• Developing Brain Imaging Analysis Expertise for Personalizing Transcranial Electric Stimulation in Anhedonia Treatment of Patients With Bipolar Depression
  NCT05240352 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 50 Years · Sex: All (male and female) · Texas: Houston
• E-Mindfulness Approaches for Living After Breast Cancer
  NCT06748222 · Phase: Phase 3 · Ages: 18 Years to 50 Years · Sex: All (male and female) · Texas: Amarillo
• Effects of Exercise and Virtual Reality on Depression
  NCT05973461 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Arlington
• Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
  NCT05892744 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Austin
• Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
  NCT06830044 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Richardson, Witchita Falls
• Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity
  NCT06923995 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Houston
• Exploring Virtual Reality Adventure Training Exergaming
  NCT05563805 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: Female · Texas: Arlington
• Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
  NCT05489042 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · Texas: Houston
• Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression
  NCT06480201 · Phase: Phase 1 · Ages: 21 Years to 45 Years · Sex: All (male and female) · Texas: Houston
• Improving Adult Protective Services Client Outcomes: A Stepped-Care Social and Mental Health Engagement Program
  NCT06257095 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · Texas: Houston
• Improving Behavioral Health for Caregivers and Children After Pediatric Injury
  NCT06856057 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Integrated Tele-Behavioral Activation and Fall Prevention for Low-income Homebound Seniors With Depression
  NCT05011864 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 100 Years · Sex: All (male and female) · Texas: Austin
• Intracranial Investigation of Neural Circuity Underlying Human Mood
  NCT05871372 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 70 Years · Sex: All (male and female) · Texas: Houston
• Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
  NCT06903819 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Lubbock
• Leveraging Adult Protective Service Interaction to Offer Evidence-Based Treatment for Depression in Elder Neglect/Self Neglect
  NCT06910267 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · Texas: Houston
• Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06966401 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire, Dallas, DeSoto, Houston
• MH-POWER for College Students on the Spectrum
  NCT07682753 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 30 Years · Sex: All (male and female) · Texas: Edinburg
• MOTIVATE to Improve Outcomes for Older Veterans With Musculoskeletal Pain and Depression
  NCT05220202 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 99 Years · Sex: All (male and female) · Texas: Dallas, Houston
• Magnetic Seizure Therapy in Bipolar Depression (MST-BpD) and Treatment Resistant Depression (MST-TRD)
  NCT04080778 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 85 Years · Sex: All (male and female) · Texas: Houston
• Mapping and Modulating the Spatiotemporal Dynamics of Socio-Affective Processing
  NCT05418894 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 70 Years · Sex: All (male and female) · Texas: Houston
• Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
  NCT06372964 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · Texas: Austin, Beaumont, Flower Mound, Houston
• Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
  NCT07494305 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: DeSoto, Richardson
• NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06911112 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: DeSoto
• Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder
  NCT06695767 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story
  NCT05809115 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
  NCT06713616 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Bellaire
• Parenting STAIR: Adapting a Trauma-Focused Parenting Intervention for Military-Connected Mothers and Their Children
  NCT06262178 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Texas: El Paso, Killeen, San Antonio
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
  NCT06559306 · Phase: Phase 3 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Texas: Austin, Bellaire, Dallas, Fort Worth
• Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus
  NCT05893485 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: Female · Texas: Houston
• Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
  NCT05869552 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 24 Years · Sex: All (male and female) · Texas: Austin, Dallas
• Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)
  NCT03906435 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · Texas: Dallas
• Psilocybin rTMS for Treatment Resistant Depression
  NCT06132178 · Phase: Phase 2 · Ages: 22 Years to 65 Years · Sex: All (male and female) · Texas: Austin
• Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
  NCT06200155 · Phase: Phase 2 · Ages: 25 Years and older · Sex: All (male and female) · Texas: Houston
• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
  NCT07002034 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Texas: Austin
• Recovery Through Inspiration, Support, and Empowerment
  NCT07051200 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 27 Years · Sex: All (male and female) · Texas: Dallas
• SAINT in Postpartum Depression (PPD)
  NCT07210255 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 45 Years · Sex: Female · Texas: Austin
• Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia
  NCT06982820 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 75 Years · Sex: All (male and female) · Texas: Houston
• Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
  NCT06129903 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Texas: Fort Bliss
• Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
  NCT06633016 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Beaumont, San Antonio, Sherman
• Study of ALTO-300 in MDD
  NCT05922878 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Texas: Dallas, Fort Worth, Missouri City, Plano
• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
  NCT05850689 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Texas: Houston, Mansfield, Richardson
• Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
  NCT06786624 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Dallas, Houston, Richmond, The Woodlands
• Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O)
  NCT05752448 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · Texas: Dallas, Houston
• TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
  NCT07048574 · Phase: Not specified · Ages: 18 Months to 11 Years · Sex: All (male and female) · Texas: Plano
• TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
  NCT06801041 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Texas: Houston
• Teen Recovery Through Inspiration, Support, and Empowerment
  NCT07170657 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years to 18 Years · Sex: All (male and female) · Texas: Dallas
• Telehealth Behavioral Activation for Teens
  NCT06273995 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: All (male and female) · Texas: Houston
• The OBSERVE Protocol
  NCT06725277 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Texas: Bellaire
• To Improve Depressive Symptoms Using a Web-App
  NCT05405803 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 60 Years · Sex: Female · Texas: Austin
• Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression
  NCT03952962 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 70 Years · Sex: All (male and female) · Texas: Dallas
• Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
  NCT07688720 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: Female · Texas: Fort Worth
• Transcutaneous Vagus Nerve Stimulation for Attention and Memory
  NCT06723743 · Phase: Not applicable (e.g. observational or device study) · Ages: 25 Years to 64 Years · Sex: All (male and female) · Texas: Houston
• Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
  NCT06423430 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years to 70 Years · Sex: All (male and female) · Texas: Austin, Dallas, Houston
• Triage Survey for Psychiatry Research Eligibility
  NCT05800925 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Texas: DeSoto
• Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
  NCT06547489 · Phase: Phase 2 · Ages: 18 Years to 64 Years · Sex: All (male and female) · Texas: Austin, DeSoto, Houston, San Antonio
• rTMS for Military TBI-related Depression
  NCT05426967 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 55 Years · Sex: All (male and female) · Texas: Fort Bliss